| Factor Information | |
|---|---|
| Data ID | 1503 |
| Factor | cyanotic ACHD |
| Description | risk factor associated with MS in ACHD |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | risk factor associated with MS in ACHD. |
| p Value | <0.001 |
| OR | 0.46 |
| Conclusion | After adjustment for age, gender, smoking, alcohol use, and exercise, the ORs for MS were 0.46 {95% con dence interval (CI) 0.35-0.57} and 1.48 (95% CI 1.14-1.92) in the cyanotic ACHD and surgically corrected ACHD groups, respectively, with an increase in the surgically corrected ACHD group. |
| Risk Factor | protective factor |
| CHD Type | |
|---|---|
| ID | 534 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/TOF/VSD/DORV/PDA/EA/AVSD/L-TGA/SV/PA, VSD, MAPCA/TA/PS/TAS/D-TGA |
| Reference | |
|---|---|
| PMID | 26413110 |
| Year | 2015 |
| Title | Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | adult | |
| Source | data | |
| Region | Seoul, Korea | |
| Method | Analysis of variance (ANOVA), Kruskal–Wallis test, χ2 test or Fisher exact test for surgically corrected CHD vs. cyanotic CHD vs control groups. | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery | |
| Group | cyanotic ACHD(Treatment) | control(Control) |
| Number | 45 | 135 |
| Age | 43.1 years | 47.1(10.3) years |
| Gender (Male: Female) | 26:19 | 59:76 |
| Marker Level | N/A | N/A |
